SciTech Development
Introducing Our Lead Cancer Drug Candidate ST-001 nanoFenretinide and New Drug Delivery Platform.
Multinational United States
Team
0
Confidence
12/100
About
Introducing Our Lead Cancer Drug Candidate ST-001 nanoFenretinide and New Drug Delivery Platform.
Links
Admin
Last Update
Dec 27, 2024
Missing
funding stage, product stage, sector, founding year, founding month, number of employees, tags, invite member, business model, address, description, video or image, funding rounds, news, markets, external profiles, not claimed
Internal
Created by
Doron York (dyork@citysidevc.com)
Created
2024-12-27T00:00:00.000Z
Recent activity
Doron York · Manual · 2024-12-27 16:41:42.000000
Doron York · Automatic · 2024-12-27 16:41:42.000000
Doron York · Automatic · 2024-12-27 16:41:42.000000